+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Monosialotettrahexosylgangliloside"

From
Neuroprotection - Methods, Drugs, Markets and Companies - Product Thumbnail Image

Neuroprotection - Methods, Drugs, Markets and Companies

  • Report
  • November 2021
  • 844 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Monosialotetrahexosylganglioside (GM1) is a glycolipid found in the cell membranes of the central nervous system. It is a major component of the myelin sheath, which is responsible for the insulation of nerve fibers and the conduction of nerve impulses. GM1 is also involved in the regulation of cell growth and differentiation, and is essential for the normal functioning of the nervous system. GM1 is used in the treatment of several neurological disorders, including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. It is believed to act as a neuroprotective agent, protecting neurons from damage and promoting their regeneration. GM1 is also used in the treatment of peripheral neuropathy, a condition characterized by nerve damage in the arms and legs. GM1 is available in the form of oral tablets, capsules, and injections. It is also available as a dietary supplement. Some companies in the GM1 market include Merck, Pfizer, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more